VancodermadminThe Emerging Combination of Tranexamic Acid and Niacinamide for Melasma Treatment
Faramarz Rafie MD / Vancoderm Academy and College (VDA) / Vancoderm Clinic (VDCMed)
Melasma is a common chronic pigmentation disorder characterized by brown or gray-brown patches that typically appear on the cheeks, forehead, upper lip, and chin. It develops due to increased melanin production and is commonly associated with sun exposure, hormonal fluctuations, inflammation, genetics, and certain medications. Melasma is more frequently seen in women and individuals with darker skin types, and it can significantly impact a patient’s confidence and quality of life.
Melasma is generally classified into two major types based on the depth of pigment deposition:
Epidermal Melasma
Epidermal melasma occurs when excess melanin is located in the superficial layers of the skin (epidermis). This type usually appears as well-defined brown patches and often responds more effectively to topical treatments and professional aesthetic procedures. Under Wood’s lamp examination, epidermal melasma typically becomes more pronounced.
Dermal Melasma
Dermal melasma involves deeper pigment deposition within the dermis. It often presents with bluish-gray or ash-brown discoloration and tends to be more resistant to treatment. Wood’s lamp examination may show minimal enhancement because the pigment is located deeper in the skin.
In many patients, a mixed pattern containing both epidermal and dermal components may also be observed, making treatment more complex and requiring long-term management strategies.
Managing melasma can be challenging because of its recurrent nature and sensitivity to UV radiation and heat. Modern treatment approaches focus not only on reducing pigmentation but also on controlling inflammation, protecting the skin barrier, and preventing recurrence. Among the emerging treatment strategies, the combination of tranexamic acid and niacinamide has gained significant attention for its effectiveness and safety profile
Understanding Tranexamic Acid in Pigmentation Management
Tranexamic acid is widely recognized for its anti-pigmentary and anti-inflammatory properties. Originally used in medicine to reduce bleeding, it has demonstrated significant benefits in treating melasma by interfering with the pathways involved in melanocyte activation and pigment production. Tranexamic acid helps reduce UV-induced pigmentation and vascular components associated with melasma, making it a valuable ingredient in modern aesthetic protocols.
It can be used in several forms, including:
- Topical formulations
- Oral therapy under medical supervision
- Mesotherapy and Microneedling-assisted delivery
The Role of Niacinamide
Niacinamide, also known as Vitamin B3, is a multifunctional skincare ingredient known for its ability to improve skin barrier function, reduce inflammation, regulate oil production, and brighten uneven skin tone. In pigmentation disorders, niacinamide works by inhibiting the transfer of melanosomes from melanocytes to surrounding skin cells, which helps reduce visible discoloration and prevent recurrence.
Additional benefits of niacinamide include:
- Reduction of post-inflammatory hyperpigmentation
- Improvement of skin texture
- Enhanced hydration and barrier repair
- Reduction in redness and irritation
Why This Combination Matters
The combination of tranexamic acid and niacinamide offers a synergistic approach to melasma management. While tranexamic acid targets pigment formation and vascular triggers, niacinamide enhances barrier repair and decreases pigment transfer. Together, they provide a comprehensive treatment strategy with lower irritation potential compared to more aggressive depigmenting agents.
This combination may be especially beneficial for:
- Sensitive skin types
- Patients with recurrent melasma
- Maintenance therapy after professional procedures
- Individuals seeking non-hydroquinone alternatives
Importance of Sun Protection
No melasma treatment protocol is complete without consistent sun protection. Daily use of broad-spectrum SPF is essential to prevent relapse and maintain treatment results. Patients should also be educated about visible light exposure, heat-induced pigmentation, and long-term skin maintenance.
Comparison with Hydroquinone
Hydroquinone has long been considered the gold standard treatment for melasma because of its strong ability to inhibit tyrosinase, an enzyme involved in melanin production. While hydroquinone can produce significant lightening effects, prolonged or inappropriate use may lead to skin irritation, inflammation, rebound hyperpigmentation, Ochronosis, and increased skin sensitivity in some patients. For this reason, many practitioners now seek safer long-term alternatives and combination therapies.
The combination of tranexamic acid and niacinamide offers a gentler and more comprehensive approach to melasma management. Rather than aggressively suppressing pigmentation alone, these ingredients target multiple pathways involved in melasma development. Tranexamic acid helps reduce melanocyte activation, vascular stimulation, and inflammation, while niacinamide decreases melanosome transfer and improves skin barrier function.
Compared with hydroquinone, tranexamic acid and niacinamide may provide:
- Lower risk of irritation and post-inflammatory hyperpigmentation
- Better tolerability for sensitive skin types
- Safer long-term maintenance therapy
- Reduced risk of rebound pigmentation
- Additional anti-inflammatory and skin barrier benefits
Although hydroquinone may still provide faster visible lightening in some epidermal melasma cases, the combination of tranexamic acid and niacinamide has shown promising results in improving pigmentation with fewer side effects and better patient compliance. Many modern aesthetic protocols now combine these ingredients with sun protection, antioxidants, and minimally invasive procedures to achieve more stable and long-lasting outcomes.
Phototoxicity Profile of Tranexamic Acid and Niacinamide
- Tranexamic Acid does not increase the skin’s sensitivity to sunlight in the way that some exfoliating acids or retinoids can. It is commonly used in melasma treatment specifically because it helps reduce UV-induced pigmentation and inflammation.
- Niacinamide (Vitamin B3) is also non-phototoxic and is actually known for strengthening the skin barrier, reducing inflammation, and helping protect the skin from environmental stressors.
However, even though these ingredients are not phototoxic, patients with melasma should still use:
- Broad-spectrum SPF 30–50 daily
- Sun-protective measures such as hats and avoiding excessive heat exposure
This is because melasma itself is highly triggered by UV radiation, visible light, and heat exposure, not because tranexamic acid or niacinamide make the skin photosensitive.
General Clinical Guidance (Topical Use)
- Niacinamide:
Once to twice daily (AM and/or PM)
→ Very stable, well-tolerated, and suitable for long-term daily use. - Tranexamic Acid (topical):
Once or twice daily depending on formulation strength and skin tolerance
→ Commonly used in the evening, but can also be used twice daily in well-tolerated formulations.
Combination Use (Serum or Cream Formulation)
- Most commercial or compounded products containing both are used:
Twice daily (morning and night)
Important Clinical Notes
- Start once daily in sensitive skin or reactive melasma patients, then increase to twice daily if tolerated.
- Always combine with daily broad-spectrum SPF, because treatment efficacy depends heavily on UV protection.
- Overuse does not improve results and may increase irritation in some individuals (especially if other actives are included in the regimen).
Thank you.